Profile
Ulf Sewerin is currently the Chief Executive Officer at AddBIO AB since 2012.
Prior to this, he worked as a Director at Doxa AB.
Ulf Sewerin active positions
| Companies | Position | Start |
|---|---|---|
AddBIO AB
 AddBIO AB BiotechnologyHealth Technology AddBIO AB provides bone implant technology solutions. It offers Zolidd, a bioactive nanolayer with a bone strengthening drug. The firm's Zolidd is used in the areas of dental and trauma implants. It also offers Zolidiser, a machine to add bone-strengthening drugs to implants. The company was founded by Per Aspenberg and Trine Vikinge in 2008 and is headquartered in Linköping, Sweden. | Chief Executive Officer | 2012-08-30 |
Former positions of Ulf Sewerin
| Companies | Position | End |
|---|---|---|
| DOXA AB | Director/Board Member | - |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| DOXA AB | Health Technology |
| Private companies | 1 |
|---|---|
AddBIO AB
AddBIO AB BiotechnologyHealth Technology AddBIO AB provides bone implant technology solutions. It offers Zolidd, a bioactive nanolayer with a bone strengthening drug. The firm's Zolidd is used in the areas of dental and trauma implants. It also offers Zolidiser, a machine to add bone-strengthening drugs to implants. The company was founded by Per Aspenberg and Trine Vikinge in 2008 and is headquartered in Linköping, Sweden. | Health Technology |
- Stock Market
- Insiders
- Ulf Sewerin
